Tag: vascin
OSE Immunotherapeutics joins forces with GenDx for the clinical trial of its anti-cancer vascin – 11/21/2023 at 6:13 p.m.
(AOF) – OSE Immunotherapeutics announced a collaboration agreement with GenDx (Eurobio Scientific Group, a key player in the field of in vitro diagnostics). This will involve developing and validating a…